Geneva

Mu, known scientifically as B.1.621, has been classified as a “variant of interest”, the global health body said in its weekly pandemic bulletin. The WHO said the variant has mutations that indicate a risk of resistance to vaccines and stressed that further studies were needed to better understand it.